Mutant IDH1 inhibits PI3K/Akt signaling in human glioma

E-ISSN： 1097-0142|120|16|2440-2447

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.16, 2014-08, pp. : 2440-2447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PI3K/AKT signaling inhibits NOTCH1 lysosome‐mediated degradation

GENES, CHROMOSOMES AND CANCER, Vol. 54, Iss. 8, 2015-08 ,pp. : 516-526

John Wiley & Sons Inc

Access to resources Recommend Favorite

CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathy

International Journal of Molecular Medicine, Vol. 36, Iss. 6, 2015-01 ,pp. : 1507-1518

Spandidos Publications

Access to resources Recommend Favorite

ERK, PKC and PI3K/Akt Pathways Mediate Extracellular ATP and Adenosine-Induced Proliferation of U138-MG Human Glioma Cell Line

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 450-459

Karger

Access to resources Recommend Favorite

The Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway as a Therapeutic Target for the Treatment of Human Acute Myeloid Leukemia (AML)

Current Signal Transduction Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 246-256

Bentham Science Publishers

Access to resources Recommend Favorite

5,7‐Dihydroxy‐6‐Methoxy‐Flavonoids Eliminate HIV‐1 D3‐transfected Cytoprotective Macrophages by Inhibiting the PI3K/Akt Signaling Pathway

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 9, 2015-09 ,pp. : 1355-1365

John Wiley & Sons Inc

Access to resources Recommend Favorite